In prostate cancer, PTHrP expression was detected in 33% of benign prostate hyperplasia, 87% of well-differentiated tumors, and 100% of poorly differentiated and metastatic tumors, including bone metastatic tumors [102]. The gene discussed is PTHLH; the disease is prostate carcinoma.